Immuron Limited (IMRN): Price and Financial Metrics
Immuron Limited (IMRN)
Today's Latest Price: $10.97 USD
Updated Aug 7 4:00pm
Add IMRN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
IMRN Stock Summary
- For IMRN, its debt to operating expenses ratio is greater than that reported by just 0.34% of US equities we're observing.
- With a year-over-year growth in debt of -100%, Immuron Ltd's debt growth rate surpasses only 0% of about US stocks.
- The volatility of Immuron Ltd's share price is greater than that of 97.26% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Immuron Ltd, a group of peers worth examining would be BHAT, UG, GIGM, CHT, and MTSL.
- IMRN's SEC filings can be seen here. And to visit Immuron Ltd's official web site, go to www.immuron.com.au.
IMRN Stock Price Chart Technical Analysis Charts
IMRN Price/Volume Stats
| Current price | $10.97 | 52-week high | $28.99 |
| Prev. close | $11.14 | 52-week low | $1.55 |
| Day low | $10.70 | Volume | 510,107 |
| Day high | $11.74 | Avg. volume | 1,533,239 |
| 50-day MA | $8.29 | Dividend yield | N/A |
| 200-day MA | $4.35 | Market Cap | 60.62M |
Immuron Limited (IMRN) Company Bio
Immuron Limited focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. The company was founded in 1994 and is based in Australia.
Loading social stream, please wait...